Kidney Transplant Clinical Trials in Omaha, Nebraska

3 studies are recruiting for kidney transplant in Omaha, Nebraska right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

    The primary objective of this study is to demonstrate the efficacy of ravulizumab vs placebo in reducing the severity of DGF as measured by time to freedom from dialysis in adult participants who are at high risk of DGF after undergoing transplant of deceased donor kidney.

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Research Site, Omaha, Nebraska
    Locations
    130 in total
    Run by
    Alexion Pharmaceuticals, Inc.

    See if you can join NCT06830798 on ClinicalTrials.gov

  2. Empagliflozin Treatment in Kidney Transplant Recipients

    Kidney transplantation improves the health and quality of life for those Veterans with end stage kidney disease (ESKD). While early patient and graft survival are excellent, long-term outcomes continue to be challenging. Patient death with existing kidney graft function occurs in about half of all …

    Stage
    Phase 4
    Ages
    19 and older
    Site
    Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha, Nebraska
    Locations
    5 in total
    Run by
    VA Office of Research and Development

    See if you can join NCT06013865 on ClinicalTrials.gov

  3. Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation

    800 adult first time kidney transplant recipients will be enrolled in the Observational Study and followed to evaluate their Human Leukocyte Antigen (HLA)-DR/DQ molecular mismatch (mMM) score as a risk-stratifying prognostic biomarker. Six months after transplant the study will identify those who m…

    Stage
    Phase 2
    Ages
    18 to 70
    Site
    University of Nebraska Medical Center: Transplantation, Omaha, Nebraska
    Locations
    15 in total
    Run by
    National Institute of Allergy and Infectious Diseases (NIAID)

    See if you can join NCT05917522 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.